Xuexiang Du

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder”.

CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder

Cell Metabolism(2022)10.1016/j.cmet.2022.07.005

N/A

1.8DataRank · unranked

68 citations

Mingyue Liu, Jifeng Zhang, Nicholas K. Brown, Peng Zhang, Yan Zhang +11 more

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.01.530608

N/A

0.165DataRank · unranked

2 citations

Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more

CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect

Signal Transduction and Targeted Therapy(2022)10.1038/s41392-022-01030-x

N/A

0DataRank · unranked

14 citations

Xu Wang, Xuexiang Du, Yan Zhang, Chunxia Ai, Siwen Hu‐Lieskovan +5 more

Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4– and PD-1–targeted immunotherapy

Science Translational Medicine(2023)10.1126/scitranslmed.abm5663

N/A

0DataRank · unranked

18 citations

Xu Wang, Xuexiang Du, Wei Wu, Yan Zhang, Peng Zhang +8 more

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

eLife(2023)10.7554/elife.87281

N/A

0DataRank · unranked

7 citations

Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

eLife(2023)10.7554/elife.87281.3

N/A

0DataRank · unranked

1 citations

Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

(2023)10.7554/elife.87281.1

N/A

0DataRank · unranked

0 citations

Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more

Reviewer #2 (Public Review): CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

(2023)10.7554/elife.87281.1.sa1

N/A

0DataRank · unranked

0 citations

Xuexiang Du, Liu Mingyue, Xu Wang, Wei Wu, Chunxia Ai +4 more

Reviewer #1 (Public Review): CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

(2023)10.7554/elife.87281.1.sa2

N/A

0DataRank · unranked

0 citations

Xuexiang Du, Liu Mingyue, Xu Wang, Wei Wu, Chunxia Ai +4 more

Reviewer #3 (Public Review): CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

(2023)10.7554/elife.87281.2.sa0

N/A

0DataRank · unranked

0 citations

Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment

(2023)10.7554/elife.87281.2

N/A

0DataRank · unranked

0 citations

Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more

Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies

Cancers(2020)10.3390/cancers12020284

N/A

0DataRank · unranked

14 citations

Xinxin Xiong, Christian Rolfo, Xuexiang Du, Yan Zhang, Han Yang +6 more

pH-dependent dissociation from CTLA-4 in early endosomes improves both safety and antitumor activity of anti-CTLA-4 antibodies

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2422731122

N/A

0DataRank · unranked

5 citations

Jin Li, Kepeng Yan, Haoyue Zhou, Song Mei, Benyu Wang +11 more

Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues

Journal of Clinical Investigation(2022)10.1172/jci150846

N/A

0DataRank · unranked

141 citations

Yan Liu, Mingyue Liu, Xuexiang Du, Martin Devenport, Pan Zheng +3 more